TNSN04096A1 - Compositions polymeres a liberation controlee comprenant des composes favorisant la croissance osseuse. - Google Patents
Compositions polymeres a liberation controlee comprenant des composes favorisant la croissance osseuse.Info
- Publication number
- TNSN04096A1 TNSN04096A1 TNP2004000096A TNSN04096A TNSN04096A1 TN SN04096 A1 TNSN04096 A1 TN SN04096A1 TN P2004000096 A TNP2004000096 A TN P2004000096A TN SN04096 A TNSN04096 A TN SN04096A TN SN04096 A1 TNSN04096 A1 TN SN04096A1
- Authority
- TN
- Tunisia
- Prior art keywords
- bone growth
- controlled release
- polymer compositions
- release polymer
- enhancing compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
LA PRESENTE INVENTION CONCERNE UN SYSTEME PERFECTIONNE POUR LA LIBERATION CONTROLEE D'UN COMPOSE FAVORISANT LA CROISSANCE OSSEUSE; ET UNE COMPOSITION FLUIDE POUR SA FORMATION. LA COMPOSITION FLUIDE EST CONSTITUEE D'UN COMPOSE FAVORISANT LA CROISSANCE OSSEUSE; D'UN POLYMERE THERMOPLASTIQUE ET D'UN SOLVANT ORGANIQUE. LA COMPOSITION FLUIDE EST CAPABLE DE FORMER UNE MATRICE POLYMERE SOLIDE MICROPOREUSE BIODEGRADABLE ET/OU BIOERODABLE. LA MATRICE EST UTILE COMME IMPLANT CHEZ DES PATIENTS (HOMME ET ANIMAUX) POUR DELIVRER UN COMPOSE FAVORISANT LA CROISSANCE OSSEUSE A CERTAINS TISSUS.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33725501P | 2001-11-30 | 2001-11-30 | |
PCT/IB2002/004965 WO2003045351A1 (fr) | 2001-11-30 | 2002-11-20 | Compositions polymeres a liberation controlee de composes stimulant la formation osseuse |
Publications (1)
Publication Number | Publication Date |
---|---|
TNSN04096A1 true TNSN04096A1 (fr) | 2006-06-01 |
Family
ID=23319774
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TNP2004000096A TNSN04096A1 (fr) | 2001-11-30 | 2004-05-28 | Compositions polymeres a liberation controlee comprenant des composes favorisant la croissance osseuse. |
Country Status (34)
Country | Link |
---|---|
US (2) | US20030104031A1 (fr) |
EP (1) | EP1448166A1 (fr) |
JP (1) | JP4903985B2 (fr) |
KR (1) | KR100629380B1 (fr) |
CN (1) | CN1599598A (fr) |
AP (1) | AP1781A (fr) |
AR (1) | AR037462A1 (fr) |
AU (2) | AU2002347502A1 (fr) |
BR (1) | BR0214610A (fr) |
CA (1) | CA2468703C (fr) |
DO (1) | DOP2002000534A (fr) |
EA (1) | EA011350B1 (fr) |
EC (1) | ECSP045124A (fr) |
GE (1) | GEP20063951B (fr) |
GT (1) | GT200200242A (fr) |
HR (1) | HRP20040486A2 (fr) |
HU (1) | HUP0402135A3 (fr) |
IL (1) | IL161835A0 (fr) |
IS (1) | IS7217A (fr) |
MA (1) | MA27084A1 (fr) |
MX (1) | MXPA04003723A (fr) |
NO (1) | NO20042273L (fr) |
NZ (1) | NZ533115A (fr) |
OA (1) | OA12731A (fr) |
PA (1) | PA8559001A1 (fr) |
PE (1) | PE20030581A1 (fr) |
PL (1) | PL370085A1 (fr) |
SV (1) | SV2004001421A (fr) |
TN (1) | TNSN04096A1 (fr) |
TW (1) | TW200300695A (fr) |
UA (1) | UA76792C2 (fr) |
WO (1) | WO2003045351A1 (fr) |
YU (1) | YU35004A (fr) |
ZA (1) | ZA200402755B (fr) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7074425B2 (en) * | 2002-09-26 | 2006-07-11 | Bonewax, Llc | Hemostatic compositions and methods |
WO2004071356A2 (fr) * | 2003-02-10 | 2004-08-26 | Smith & Nephew, Inc. | Dispositifs resorbables |
GB0307011D0 (en) | 2003-03-27 | 2003-04-30 | Regentec Ltd | Porous matrix |
CN1909911A (zh) * | 2003-10-01 | 2007-02-07 | 浩鼎生技公司 | 通过给予氨基糖治疗哺乳动物的疾病状态及其用途 |
GB0329654D0 (en) | 2003-12-23 | 2004-01-28 | Smith & Nephew | Tunable segmented polyacetal |
US8123787B2 (en) | 2004-10-28 | 2012-02-28 | Ogilvie James W | Method of treating scoliosis using a biological implant |
US8641738B1 (en) | 2004-10-28 | 2014-02-04 | James W. Ogilvie | Method of treating scoliosis using a biological implant |
JP2009504929A (ja) * | 2005-08-18 | 2009-02-05 | スミス アンド ネフュー ピーエルシー | 高強度デバイス及び複合材料 |
CN100443065C (zh) * | 2006-01-26 | 2008-12-17 | 上海交通大学 | 用于颌面骨缺损修复的复合体系植入体单元 |
EP2120745B1 (fr) | 2006-11-30 | 2010-12-29 | Smith & Nephew, Inc. | Matériau composite renforcé par des fibres |
EP2142353A1 (fr) | 2007-04-18 | 2010-01-13 | Smith & Nephew PLC | Moulage par expansion de polymères à mémoire de forme |
WO2008131197A1 (fr) | 2007-04-19 | 2008-10-30 | Smith & Nephew, Inc. | Polymères à mémoire de forme multimodaux |
AU2008243035B2 (en) | 2007-04-19 | 2013-09-12 | Smith & Nephew, Inc. | Graft fixation |
US8062739B2 (en) * | 2007-08-31 | 2011-11-22 | Zimmer, Inc. | Hydrogels with gradient |
US20090181068A1 (en) * | 2008-01-14 | 2009-07-16 | Dunn Richard L | Low Viscosity Liquid Polymeric Delivery System |
EP2172189A1 (fr) * | 2008-10-01 | 2010-04-07 | Novartis AG | Compositions pharmaceutiques |
PL2323623T3 (pl) | 2008-08-12 | 2017-04-28 | Novartis Ag | Kompozycje farmaceutyczne |
US20100130959A1 (en) * | 2008-10-15 | 2010-05-27 | Palmetto Biomedical, Inc. | Device and method for delivery of therapeutic agents via artificial internal implants |
US9642658B2 (en) | 2008-10-15 | 2017-05-09 | Orthoclip Llc | Device and method for delivery of therapeutic agents via internal implants |
BR112012002341A8 (pt) | 2009-08-06 | 2017-10-10 | Koninklijke Philips Electronics Nv | Semente radioativa para uso na terapia oncológica e método de terapia oncológica |
AU2013201121A1 (en) | 2011-09-20 | 2013-04-04 | Vical Incorporated | Synergistic anti-tumor efficacy using alloantigen combination immunotherapy |
CN104189954B (zh) * | 2014-09-19 | 2017-03-29 | 中国科学院长春应用化学研究所 | 一种原位固化组织工程支架及其制备方法 |
RU2571548C1 (ru) * | 2014-12-17 | 2015-12-20 | Федеральное государственное бюджетное учреждение науки Институт органической и физической химии им. А.Е. Арбузова Казанского научного центра Российской академии наук | Ветеринарное имплантируемое средство пролонгированного действия (варианты) |
SG11201804037XA (en) | 2015-11-16 | 2018-06-28 | Evonik Roehm Gmbh | Injection solution comprising a non-nucleoside reverse-transcriptase inhibitor and poly(lactide-co-glycolide) |
CN109498852B (zh) * | 2018-12-29 | 2022-06-24 | 广州噢斯荣医药技术有限公司 | 治疗骨科疾病的生物降解材料及其应用 |
JP2023500506A (ja) | 2019-11-04 | 2023-01-06 | アストラゼネカ・アクチエボラーグ | 癌を治療するための組み合わせ療法 |
EP4255357A1 (fr) | 2020-12-29 | 2023-10-11 | Sino Medical Sciences Technology Inc. | Endoprothèse à élution de médicament |
WO2024089418A1 (fr) | 2022-10-24 | 2024-05-02 | Cancer Research Technology Limited | Sensibilisation tumorale à des inhibiteurs de points de contrôle avec modificateur d'état redox |
WO2024089417A1 (fr) | 2022-10-24 | 2024-05-02 | Memorial Sloan-Kettering Cancer Center | Stratification de tumeurs pour déterminer la sensibilité à un inhibiteur de point de contrôle immunitaire |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09511666A (ja) * | 1994-04-08 | 1997-11-25 | アトリックス・ラボラトリーズ・インコーポレイテッド | 医療装置で使用する付随的ポリマー系 |
WO1996021427A1 (fr) | 1995-01-09 | 1996-07-18 | Atrix Laboratories, Inc. | Systeme d'administration d'un polymere liquide |
UA59384C2 (uk) * | 1996-12-20 | 2003-09-15 | Пфайзер, Інк. | Похідні сульфонамідів та амідів як агоністи простагландину, фармацевтична композиція та способи лікування на їх основі |
ATE203157T1 (de) * | 1996-12-20 | 2001-08-15 | Alza Corp | Injizierbare depotgelzubereitung und herstellungsverfahren |
UA67754C2 (uk) * | 1997-10-10 | 2004-07-15 | Пфайзер, Інк. | Агоністи простагландину, фармацевтична композиція на їх основі (варіанти), спосіб нарощення та збереження кісткової маси у хребетних та спосіб лікування (варіанти) |
US7128927B1 (en) * | 1998-04-14 | 2006-10-31 | Qlt Usa, Inc. | Emulsions for in-situ delivery systems |
US6143314A (en) * | 1998-10-28 | 2000-11-07 | Atrix Laboratories, Inc. | Controlled release liquid delivery compositions with low initial drug burst |
-
2002
- 2002-11-20 HU HU0402135A patent/HUP0402135A3/hu unknown
- 2002-11-20 UA UA20040504054A patent/UA76792C2/uk unknown
- 2002-11-20 EA EA200400608A patent/EA011350B1/ru not_active IP Right Cessation
- 2002-11-20 MX MXPA04003723A patent/MXPA04003723A/es active IP Right Grant
- 2002-11-20 NZ NZ533115A patent/NZ533115A/en unknown
- 2002-11-20 OA OA1200400150A patent/OA12731A/en unknown
- 2002-11-20 AP APAP/P/2004/003037A patent/AP1781A/en active
- 2002-11-20 WO PCT/IB2002/004965 patent/WO2003045351A1/fr active IP Right Grant
- 2002-11-20 CN CNA028239687A patent/CN1599598A/zh active Pending
- 2002-11-20 BR BR0214610-0A patent/BR0214610A/pt not_active IP Right Cessation
- 2002-11-20 YU YU35004A patent/YU35004A/sh unknown
- 2002-11-20 EP EP02783436A patent/EP1448166A1/fr not_active Withdrawn
- 2002-11-20 KR KR1020047008243A patent/KR100629380B1/ko not_active IP Right Cessation
- 2002-11-20 CA CA002468703A patent/CA2468703C/fr not_active Expired - Fee Related
- 2002-11-20 GE GE5596A patent/GEP20063951B/en unknown
- 2002-11-20 IL IL16183502A patent/IL161835A0/xx unknown
- 2002-11-20 PL PL02370085A patent/PL370085A1/xx not_active Application Discontinuation
- 2002-11-20 AU AU2002347502A patent/AU2002347502A1/en not_active Abandoned
- 2002-11-20 JP JP2003546854A patent/JP4903985B2/ja not_active Expired - Fee Related
- 2002-11-25 US US10/303,590 patent/US20030104031A1/en not_active Abandoned
- 2002-11-27 PE PE2002001144A patent/PE20030581A1/es not_active Application Discontinuation
- 2002-11-27 GT GT200200242A patent/GT200200242A/es unknown
- 2002-11-28 AR ARP020104597A patent/AR037462A1/es unknown
- 2002-11-28 PA PA20028559001A patent/PA8559001A1/es unknown
- 2002-11-28 DO DO2002000534A patent/DOP2002000534A/es unknown
- 2002-11-29 TW TW091134882A patent/TW200300695A/zh unknown
- 2002-11-29 SV SV2002001421A patent/SV2004001421A/es not_active Application Discontinuation
-
2004
- 2004-04-07 IS IS7217A patent/IS7217A/is unknown
- 2004-04-08 ZA ZA200402755A patent/ZA200402755B/en unknown
- 2004-05-20 MA MA27688A patent/MA27084A1/fr unknown
- 2004-05-28 EC EC2004005124A patent/ECSP045124A/es unknown
- 2004-05-28 TN TNP2004000096A patent/TNSN04096A1/fr unknown
- 2004-05-31 HR HR20040486A patent/HRP20040486A2/hr not_active Application Discontinuation
- 2004-06-01 NO NO20042273A patent/NO20042273L/no not_active Application Discontinuation
-
2008
- 2008-10-24 US US12/257,803 patent/US8017144B2/en not_active Expired - Fee Related
-
2009
- 2009-01-13 AU AU2009200125A patent/AU2009200125B2/en not_active Ceased
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TNSN04096A1 (fr) | Compositions polymeres a liberation controlee comprenant des composes favorisant la croissance osseuse. | |
US10286102B2 (en) | Organophosphorous, multivalent metal compounds, and polymer adhesive interpenetrating network compositions and methods | |
Müller et al. | Polyphosphate: a morphogenetically active implant material serving as metabolic fuel for bone regeneration | |
EP1566186B1 (fr) | Materiau d'apatite/collagene poreux reticule contenant un composite d'apatite/collagene auto-organise et son procede de production | |
US8765189B2 (en) | Organophosphorous and multivalent metal compound compositions and methods | |
US20090048145A1 (en) | In situ hardening paste, its manufacturing and use | |
ATE381314T1 (de) | Biokeramische zusammensetzung | |
US7989532B2 (en) | RGD polypeptide grafted poly (glycolic acid-L-lysine-L-lactic acid) / β tricalcium phosphate composite material and preparation method thereof | |
Shi et al. | Variation of the effect of calcium phosphate enhancement of implanted silk fibroin ligament bone integration | |
Renier et al. | Development and characterization of a biodegradable polyphosphate | |
US8075562B2 (en) | Controlled release of biopharmaceutical growth factors from hydroxyapatite coating on bioresorbable interference screws used in cruciate ligament reconstruction surgery | |
CN102368999A (zh) | 抗坏血酸磷酸酯缓释体系 | |
US8741982B2 (en) | Bioactive bone cement and method for the production thereof | |
ATE279950T1 (de) | Zusammensetzung zur implantation in den menschlichen und tierischen körper | |
DE69224131D1 (de) | Polymerzusammensetzungen zur Verwendung als Implantate mit verzögerter Abgabe | |
IL122472A (en) | Compositions of fgf9 as a specific ligand for fgfr3 and uses thereof | |
CN105263438A (zh) | 用于多发性骨髓瘤损害增量和骨质疏松症的可注射生物可降解性骨基质 | |
CN110139665A (zh) | 包含其中骨组织选择性肽与甲状旁腺激素(pth)或其片段结合的融合肽的药物组合物和生物材料 | |
KR101472745B1 (ko) | 표면개질된 하이드록시아파타이트를 함유하는 생체접착제 및 그의 용도 | |
JP5344417B2 (ja) | 水油界面を利用した薬物−シリカ封入体の製造法 | |
WO2007083643A1 (fr) | Biomateriau pour osteogenese contenant un promoteur de l'osteogenese et un nanogel | |
Heybeli et al. | Low-cost antibiotic loaded systems for developing countries | |
FR2830249A1 (fr) | Composition de ciment hydraulique a base de carbonates de calcium | |
Abramson | Selected bulk and surface properties and biocompatibility of a new class of tyrosine-derived polycarbonates | |
Puleo et al. | Tissue Repair and Regeneration Following Orthopedic and Craniofacial Trauma |